RAYMOND JAMES & ASSOCIATES - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,022
-11.7%
15,480
+1.3%
0.00%
Q2 2023$6,823
-48.2%
15,280
-4.9%
0.00%
Q1 2023$13,178
-44.8%
16,071
+5.0%
0.00%
Q4 2022$23,868
-27.7%
15,300
-20.1%
0.00%
Q3 2022$33,000
-32.7%
19,157
-32.9%
0.00%
Q2 2022$49,000
-52.0%
28,571
+0.4%
0.00%
Q1 2022$102,000
-34.2%
28,471
-8.6%
0.00%
Q4 2021$155,000
-32.3%
31,141
-2.4%
0.00%
Q3 2021$229,000
+9.0%
31,921
+41.2%
0.00%
Q2 2021$210,000
-4.5%
22,614
-4.7%
0.00%
Q1 2021$220,000
-18.2%
23,725
-21.8%
0.00%
Q4 2020$269,000
-23.1%
30,358
+0.8%
0.00%
Q3 2020$350,000
-47.3%
30,130
+22.3%
0.00%
-100.0%
Q2 2020$664,000
+302.4%
24,629
+11.2%
0.00%
Q1 2020$165,000
+126.0%
22,158
-0.0%
0.00%
Q4 2019$73,000
+97.3%
22,163
+22.5%
0.00%
Q3 2019$37,000
-19.6%
18,088
+16.1%
0.00%
Q2 2019$46,000
-20.7%
15,5740.0%0.00%
Q1 2019$58,000
-43.1%
15,574
-38.7%
0.00%
Q4 2018$102,000
+61.9%
25,395
+122.5%
0.00%
Q3 2018$63,000
-6.0%
11,413
+12.9%
0.00%
Q1 2017$67,000
-8.2%
10,113
-3.8%
0.00%
Q4 2016$73,000
-38.1%
10,513
-17.3%
0.00%
Q3 2016$118,000
+12.4%
12,713
+12.4%
0.00%
Q2 2016$105,000
+16.7%
11,313
+9.8%
0.00%
Q1 2016$90,00010,3000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders